通过负调节器调节的GPR3的机制和功能
Geng Chen1,2,3, Jana Bláhová4, Nico Staffen4
1School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China.
Nature communications
|August 27, 2025
概括
研究人员发现一种新的药物阻断G蛋白结合受体 (GPCRs). 一种名为AF64394的药物向GPR3二元体,阻止它们发出信号,为代谢和中枢神经系统疾病治疗提供新的途径.
科学领域:
- 生物化学
- 结构生物学
- 药理学
背景情况:
- G蛋白结合受体 (GPCR) 是主要的药物标.
- 艾洛斯特基调节器可以精确控制GPCR活性.
- GPR3与代谢和中枢神经系统疾病有关.
研究的目的:
- 阐明GPR3的异质调节机制.
- 调查GPR3二元化对其功能的作用.
- 为了确定AF64394抑制的结构基础.
主要方法:
- 用于研究GPR3二元化和信号的细胞测试.
- 低温电子显微镜 (cryo-EM) 用于结构的确定.
- 用于分析G蛋白合的生物化学测试.
主要成果:
- 在活细胞中,GPR3形成构成性同位素.
- AF64394作为一个针对二次 GPR3 的负基调制剂 (NAM).
- 冷-电磁结构显示AF64394在二元接口上的结合,稳定不活跃的形状并减少Gs合.
结论:
- AF64394通过特定于二元体的机制抑制了GPR3的信号传递.
- 这项研究揭示了一种针对GPCR二次体的新抑制策略.
- 这些发现对开发针对二元 GPCR 的代谢和中枢神经系统疾病的药物具有重要意义.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Activation and Inactivation of G Proteins
7.6K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.6K
G-Protein Gated Ion Channels
4.8K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.8K
G Protein-coupled Receptors
13.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.3K
GPCR Desensitization
6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K
Transducer Mechanism: G Protein–Coupled Receptors
2.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.4K


